Publication Name	World Journal of Clinical Cases
Manuscript ID	34118
Country	Türkiye

Received	2017-03-28 15:41
Peer-Review Started	2017-03-29 17:19
To Make the First Decision	2017-05-08 15:30
Return for Revision	2017-05-09 17:51
Revised	2017-05-16 10:57
Second Decision	2017-05-24 01:25
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2017-05-31 02:51
Articles in Press	2017-05-31 02:51
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-08-08 07:21
Publish the Manuscript Online	2017-08-16 04:11

ISSN	2307-8960 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, Research & Experimental
Manuscript Type	Minireviews
Article Title	Treatment of sepsis: What is the antibiotic choice in bacteremia due to carbapenem resistant Enterobacteriaceae?
Manuscript Source	Invited Manuscript
All Author List	Fatema Alhashem, Nicolette Leonie Tiren-Verbeet, Emine Alp and Mehmet Doganay
Funding Agency and Grant Number
Corresponding Author	Mehmet Doganay, MD, Department of Infectious Diseases, Faculty of Medicine, Erciyes University, Melikgazi District, Kayseri 38039, Türkiye. mdoganay@erciyes.edu.tr
Key Words	Carbapenem resistant Enterobacteriaceae; Sepsis; Bacteraemia; Bacteremia; Treatment; Antibiotics
Core Tip	Carbapenem resistant Enterobacteriaceae (CRE) is the most notorious pathogens contributing to a significant morbidity and mortality rate in septic patients especially in the intensive care unit. The most appropriate antimicrobial therapy to treat CRE is still controversial. This review is conducted to discuss the effectiveness of available therapies at this moment and to elaborate on different promising drugs that are still under investigation in order to win the combat on rising antimicrobial resistance.
Publish Date	2017-08-16 04:11
Citation	Alhashem F, Tiren-Verbeet NL, Alp E, Doganay M. Treatment of sepsis: What is the antibiotic choice in bacteremia due to carbapenem resistant Enterobacteriaceae? World J Clin Cases 2017; 5(8): 324-332
URL	http://www.wjgnet.com/2307-8960/full/v5/i8/324.htm
DOI	http://dx.doi.org/10.12998/wjcc.v5.i8.324

Full Article (PDF)	WJCC-5-324.pdf
Full Article (Word)	WJCC-5-324.doc
Manuscript File	34118-Review.docx
Answering Reviewers	34118-Answering reviewers.pdf
Audio Core Tip	34118-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	34118-Conflict-of-interest statement.pdf
Copyright License Agreement	34118-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	34118-Language certificate.pdf
Peer-review Report	34118-Peer-review(s).pdf
Scientific Misconduct Check	34118-Scientific misconduct check.pdf
Scientific Editor Work List	34118-Scientific editor work list.pdf